The Economic Burden of Gastrointestinal Stromal Tumor (GIST) Recurrence in Patients Who Have Received Adjuvant Imatinib Therapy

Journal of Medical Economics - United Kingdom
doi 10.3111/13696998.2014.991787
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Informa Healthcare


Related search